127. Brausi M, Oddens J, Sylvester R, Bono A, van de Beek C, van Andel G, Gontero P, Turkeri L, Marreaud S, Collette S, Oosterlinck W. Side Effects of Bacillus Calmette-Guérin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG. Eur Urol. 65(1):69-76, 2014.

126. Turker P, Bas E, Bozkurt S, Günlüsoy B, Sezgin A, Postacı H, Turkeri L. Presence of highPanel6 grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival. Urol Oncol. 31(1):93-98, 2013.

125. Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, Turkeri L, Yazici S, Ozen H; Society of Urooncology Study Group for Kidney Cancer Prognosis. A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer. Jpn J Clin Oncol. 43(1):63-68, 2013.

124. Oddens J, Brausi M, Sylvester R, Bono A, van de Beek C, van Andel G, Gontero P, Hoeltl W, Turkeri L, Marreaud S, Collette S, Oosterlinck W. Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. Eur Urol. 63(3):462-472, 2013.

123. Kuzgunbay B, Yaycioglu O, Soyupak B, Kayis AA, Ayan S, Yavascaoglu I, Cal C, Beduk Y; Collaborators: Aslan G., Mungan A., Kaplan M., Muezzinoglu T., Bozlu M., Turkeri L. Turkish Study Group of Public Awareness in Testicular Cancer. Public awareness of testicular cancer and self-examination in Turkey: a multicenter study of Turkish Urooncology Society. Urol Oncol. 31(3):386-391, 2013.

122. Atasoy BM, Dane F, Alsan Cetin I, Ozgen Z, Ucuncu Kefeli A, Ibrahimov R, Turhal NS, Abacioglu U, Turkeri L. Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients. Clin Transl Oncol. 2013 Apr 25. [Epub ahead of print] PubMed PMID:

121. Ozveren B, Türkeri L. Massive rectal bleeding after prostate biopsy controlled by endoclipping in a patient using acetylsalicylic acid. Can Urol Assoc.7(5-6):E442-444, 2013.

120. Tavukcu HH, Mangir N, Ozyurek M, Turkeri L. Preliminary Results of Noninvasive Detection of TMPRSS2:ERG Gene Fusion in a Cohort of Patients With Localized Prostate Cancer. Korean J Urol. 54(6):359-363, 2013.

119. Tinay I, Temiz Y, Ilker Y, Tuglular S, Turkeri L. An alternative for short renal vein during kidney transplantation: long-term experience with polyethylene  terephthalate (Dacron) vascular graft. Urology. 82(1):245-247, 2013.

118. Aslan G, Baltaci S, Akdogan B, Kuyumcuoğlu U, Kaplan M, Cal C, Adsan O, Turkolmez K, Ugurlu O, Ekici S, Faydaci G, Mammadov E, Turkeri L, Ozen H, Beduk Y. A prospective randomized multicenter study of Turkish Society of Urooncology comparing two different mechanical bowel preparation methods for radical cystectomy. Urol Oncol. 2013 Jul;31(5):664-670, 2013.

117. Turker P, Turkeri L. Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer. Arch Esp Urol. 66(9):833-840, 2013.

116.. Bez Y., Topçuoğlu V., Kemal KM., Demir A., Türkeri L. Differences in psychological distress and quality of life in patients with prostate cancer based on stage of the disease.. J Mood Disorders., 3: 23-27, 2013.

115. Divrik RT, Türkeri L, Şahin AF, Akdoğan B, Ateş F, Çal Ç, Baltacı S; Urooncology Association. Prediction of response to androgen deprivation therapy and castration resistance in primary metastatic prostate cancer. Urol Int. 88(1):25-33, 2012.

114. Guney AI, Ergec DS, Tavukcu HH, Koc G, Kirac D, Ulucan K, Javadova D, Turkeri L. Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer. Genet Test Mol Biomarkers. 16(7):672-678, 2012.

113. Turkeri LN. Words of wisdom. Re: Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. Eur Urol. 62(1):184-185, 2012.

112. Ekici S, Eroğlu A, Doğan Ekici AI, Türkeri L. Clusterin immunoreactivity as a predictive factor for progression of non-muscle-invasive bladder carcinoma. Urol Int.86(1):31-35, 2011.

111. Aslan G, Baltaci S, Cal C, Turkeri L, Gunlusoy B, Adsan O, Sanli O, Tansug Z, Horasanli K, Uygur C, Ozen H. Bowel preparation and peri-operative management for radical cystectomy in Turkey: Turkish Urooncology Association multicenter survey. Urol J. 8(2):113-119, 2011.

110. Türkeri L. Prostate cancer: to screen or not to screen. Editorial Comment. Arch Esp Urol. 64(5):419-20, 2011.

109. Türkeri L, Tanıdır Y, Çal Ç, Özen H, Şahin H; Turkish Urooncology Society. Comparison of the efficacy of single or double intravesical epirubicin instillation in the early postoperative period to prevent recurrences in non-muscle-invasive urothelial carcinoma of the bladder: prospective, randomized  multicenter study. Urol Int. 85(3):261-265, 2010.

108. Brewster S, Turkeri L, Brausi M, Ravery V, Djavan B. 5A prospective survey of current prostate biopsy practices among oncological urologists. Can J Urol. 17(2):5071-5076, 2010.

107. Turkeri L, Onol FF, Ozyurek M. Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens. Urol Oncol. 28(3):290-295, 2010.

106. Martínez-Piñeiro L, Djakovic N, Plas E, Mor Y, Santucci RA, Serafetinidis E, Turkeri LN, Hohenfellner M; European Association of Urology. EAU Guidelines on Urethral Trauma. Eur Urol. 57(5):791-803, 2010.

105. Türkeri L. Editorial comment. Can J Urol. 17(3):5169, 2010.

104. Türkeri L. Words of wisdom. Re: Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol. 58(5):793, 2010.

103. Tavukçu HH, Akbal C, Tinay I, Simşek F, Türkeri L. Outcome of preemptive penile rehabilitation before bilateral cavernosal nerve injury in rats. World J Urol. 28(6):735-740, 2010.

102. Türkeri L. Words of wisdom. Re: Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? Eur Urol. 55(4):993, 2009.

101. Mutlu N, Türkeri LN, Yencilek F, Demir A, Emerk K. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range. Can J Urol. 16(2):4558-4567, 2009.

100. Akbal C, Türker P, Ozyürek M, Erkanli G, Simşek F, Türkeri L. A new cause of  male infertility after cisplatin exposure: the effect of cisplatin on Y chromosomes. Urology. 73(5):1145-1149, 2009.

99. Eskicorapci SY, Türkeri L, Karabulut E, Cal C, Akpinar H, Baltaci S, Baykal K; Turkish Validation Study Group of Kattan Preoperative Nomogram, Kattan MW, Ozen H. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society. Urology.;74(6):1289-1295, 2009.

98. Akbal C, Tinay I, Simşek F, Turkeri LN. Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment. Int Urol Nephrol. 2008;40(2):355-363, 2008.

97. Cimsit NC, Baltacioglu F, Cengic I, Akpinar IN, Ilker Y, Turkeri L. Transarterial glue embolization in iatrogenic renovascular injuries. Int Urol Nephrol. 40(4):875-879, 2008.

96. Türkeri L. Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer. Eur Urol. 53(3):562-563, 2008.

95. Akbal C, Türker P, Tavukçu HH, Simşek F, Türkeri L. Erectile function inprostate cancer-free patients who underwent prostate saturation biopsy. Eur Urol. 53(3):540-544, 2008.

94. Gürdal M, Kireççi S, Huri E, Karaman I, Türkeri L. Correlation between duration of varicocele and apoptosis in testicular tissue in an experimental model. Urology. 72(4):933-936, 2008.

93. Bozkurt SU, Erbarut I, Yazici C, Kaya H, Türkeri L. Nephrogenic adenoma of the ureter: case report. Int Urol Nephrol. 39(1):65-69, 2007.

92. Demir A, Yazici CM, Eren F, Türkeri L. Case report: good prognosis in leiomyosarcoma of the kidney. Int Urol Nephrol. 39(1):7-10, 2007.

91. Türkeri L. The extent of lymph node dissection in patients with localized prostate cancer: debate continues. Eur Urol. 51(6):1472-1474, 2007.

90. Türkeri LN, Temiz Y, Yazici CM, Tinay I. A new suture technique for anastomosis in radical retropubic prostatectomy and early removal of urethral catheter. Can J Urol. 14(6):3734-3738, 2007.

89. Onol FF, Demir A, Temiz Y, Yüksel M, Eren F, Türkeri LN. The inhibitory effect of vitamin E on cigarette smoke-induced oxidative damage to the rat urothelium: can it prevent transitional cell carcinoma? Urol Int. 78(2):150-154, 2007.

88. Kaya C, Akpinar IN, Aker F, Türkeri LN. Large Cystitis glandularis: a very rare cause of severe obstructive urinary symptoms in an adult. Int Urol Nephrol. 39(2):441-444, 2007.

87. Onol FF, Tanidir Y, Kotiloglu E, Bayramiçli M, Turhal S, Türkeri LN. Proximaltype epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention: part 2. Eur Urol. 49(3):578-580, 2006.

86. Türkeri LN, Temiz Y, Ozgur A, Onol FF. A new approach for the surgery of large renal masses: abdominal wall flap incision. Urol Int. 76(4):296-300, 2006.

85 Demir A, Tanidir Y, Kaya H, Turkeri LN. A giant adrenal pseudocyst: case report and review of the literature. Int Urol Nephrol. 38(1):167-169, 2006.

84. Onol FF, Tanidir Y, Kotiloğlu E, Bayramiçli M, Turhal S, Türkeri LN. Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention. Eur Urol. 49(2):406-407, 2006.

83. Buse S, Lynch TH, Martinez-Piñeiro L, Plas E, Serafetinides E, Turkeri L, Santucci RA, Sauerland S, Hohenfellner M; German Society for Trauma Surgery. [Urinary tract injuries in polytraumatized patients]. Unfallchirurg. 108(10):821-828, 2005.

82. Eskicorapci SY, Karabulut E, Türkeri L, Baltaci S, Cal C, Toktas G, Akpinar H, Ozer G, Sozen S, Tokuc R, Lekili M, Soylu A, Albayrak S, Sahin H, Alpar R, Ozen H. Validation of 2001 Partin tables in Turkey: a multicenter study. EurUrol.47(2):185-189, 2005.

81. Akay F., Atuğ F., Türkeri L. Partial duplication of tHE vas deferens at the level of inguinal canal. Int J Urol., 12(8): 773-775, 2005.

80. Türkeri LN and Kuczyk M. Bladder-Sparing Treatment Modalities in the Management of Invasive Bladder Cancer European Urology 4(S4):57-60, 2005.

79. Eskicorapci SY, Karabulut E, Türkeri L, Baltacı S, Cal C, Toktas G, Akpınar H, Ozer G, Sozen S, Tokuc R, Lekili M, Soylu A, Albayrak S, Sahin H, Alpar R, Ozen H. Validation of 2001PartinTables inTurkey: A Multicenter Study  Eur Urol., 47: 185–189, 2005.

78. Fatih Onol F, Ozgur A, Turkeri LN. Is the positive biopsy core percent really predictive of non-organ confined prostate carcinoma? Arch Esp Urol. 58(3):269-275, 2005.

77. Kaya C, Ozyurek M, Turkeri LN.  Comparison of microvessel densities in rat prostate tissues treated with finasteride, bicalutamide and surgical castration: a preliminary study. Int J Urol.;12(2):194-198, 2005.

76. Lynch TH, Martinez-Pineiro L, Plas E, Serafetinides E, Turkeri L, Santucci RA, Hohenfellner M.  EAU guidelines on urological trauma. Eur Urol. 47(1):1-15, 2005.

75. Gokaslan H, Turkeri L, Kavak ZN, Eren F, Sismanoglu A, Ilvan S, Durmusoglu F. Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors. Gynecol Obstet Invest. 59(1):36-40, 2005.

74. Atug F, Turkeri L, Atug O, Cal C.   Detection of Helicobacter pylori in bladder biopsy specimens of patients with interstitial cystitis by polymerase chain reaction. Urol Res. 32(5):346-349, 2004.

73. Zlotta AR, Roumeguere T, Ravery V, Hoffmann P, Montorsi F, Turkeri L, Dobrovrits M, Scattoni V, Ekane S, Bollens R, Vanden Bossche M, Djavan B, Boccon-Gibod L, Schulman CC; European Society for Urological Oncology.   Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. Eur Urol. 46(1):42-49,2004.

72. Turkeri LN. Novel Therapies in Prostate Cancer. European Urology 3(S3): 63-69, 2004.

71. Çam K, Şimsek F, Yuksel M, Türkeri L, Haklar G, Yalcin S, Akdas A.  The role of reactive oxygen species and apoptosis in the pathogenesis of varicocele in a rat model and efficiency of vitamin E treatment. Int J Androl. 27(4):228-33, 2004. (Erratum in: Int J Androl. 2004.)

70. Demir A, Onol FF, Eren F, Türkeri L.  Testis-sparing surgery in an adult with bilateral synchronous seminomatous tumor. Int J Urol. Dec;11(12):1142-1144, 2004.

69. Ozgur A, Onol FF, Turkeri LN.  Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy. Int Urol Nephrol.;36(3):369-373, 2004.

68. Demir A, Onol FF, Bozkurt S, Turkeri L.  Synchronous ipsilateral conventional renal cell and transitional cell carcinoma. Int Urol Nephrol. 36(4):499-502, 2004.

67.  Demir A, Onol FF, Turkeri L.  Paratesticular pleomorphic rhabdomyosarcoma in an adult. Int Urol Nephrol. 36(4):577-578, 2004.

66. Şimşek F., Yücel S., Aktaş M., Türkeri L. Ordinary glass spheres as an altenative injectable material for endoscopic correction of vesico ureteric reflux. J Urol, 171: 1282-1286, 2004.

65.  Ozgur A, Ilker Y, Turkeri LN.  Cervical lymph node enlargement on the right side as the initial manifestation of metastatic prostate cancer. Arch Esp Urol. 56(7):859-861, 2003.

64.  Demir A, Onol FF, Turkeri L.  Case report: malignant Sertoli cell tumor of the testis in an adult. Int Urol Nephrol. 35(4):515-516, 2003.

63.  Mutlu N, Turkeri L, Emerk K.  Analytical and clinical evaluation of a new urinary tumor marker: bladder tumor fibronectin in diagnosis and follow-up of bladder cancer. Clin Chem Lab Med. 41(8):1069-1074, 2003.

62. Şengöz M., Abacıoğlu U., Çetin İ., Türkeri L. PSA bouncing after external beam radiation for prostate cancer with or without hormonal treatment. Eur Urol, 43: 473-477, 2003.

61. Mickisch GHJ., Brausi M., Djavan B., Heidenreich A., Kuczyk M., Ravery V., Turkeri L., van Poppel H., Whelan P, Zlotta A. Rational selection of a control arm for randomised clinical trials in metastatic renal cell carcinoma. Eur Urol, 43: 670-679, 2003.

60. Kuczyk M, Turkeri L, Hammerer P, Ravery V and on behalf of the European Society for Oncological Urology. Is There a Role for Bladder Preserving Strategies in the Treatment of Muscle-Invasive Bladder Cancer?, Eur Urol, 44: 57-64, 2003.

59. Çam K., Yücel S., Türkeri L., Akdaş A. Accuracy of transrectal ultrasound guided prostate biopsy: histopathological correlation to matched prostatectomy specimens. Int J Urol., 9(5): 257-260, 2002.

58. Çam K., Yıldırım A., Özveri H., Türkeri L., Akdaş A. The efficacy of neoadjuvant chemotherapy in invasive bladder cancer. Int Urol Nephrol., 33: 49-52, 2002.

57. Ertuğrul A., Çam K., Tarcan T., Akdaş A., Türkeri L. Nuclear accumulation of protein p53 and histological changes in the rat model of unilateral cryptorchidism. Brazilian Journal of Urology, 28 (1): 57-63, 2002.

56. Türkeri L. Superficial bladder cancer and growth factor system: Potential molecular prognostic factors. Urol Integr Invest., 6(1): 63-69, 2001.

55. Çam K., Özveri H., Türkeri L., Akdaş A. The significance of hypoechoic lesion directed and transition zone biopsies in improving the diagnostic ability in prostate cancer. Brazilian Journal of Urology, 27 (3): 222-226, 2001.

54. Özveri H., Çam H.K., Tarcan T., Türkeri L., Akdaş A. The role of prostate specific antigen, Gleason score, digital rectal examination, and transrectal ultrasonography in the prediction of extracapsular prostate cancer. J. BUON., 6: 87-90, 2001.

53. Türkeri L., Özyürek M., Ersev D., Akdaş A. Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia. Arch Esp de Urol., 54:191-196, 2001.

52. Özveri H., Çam K., Tarcan T., Türkeri L., Akdaş A. Early diagnosis of prostate cancer among 1181 patients attending an urology outpatient department. J. BUON, 5: 389-392, 2000.

51. Türkeri L. Highlights in BPH . European Urology Today, 11: 1, 2000.

50. Yücel S., Türkeri L., Akdaş A. Early cystic relapse of embryonal carcinoma of testis in obturator fossa. Arch Esp de Urol., 53:87-89, 2000.

49. Çevik İ., Çam K., Türkeri L., İlker Y., Akdaş A. Pheochromocytoma associated with ipsilateral renal cell carcinoma. African J. Urol., 6: 91-93, 2000.

48. Türkeri L., Ayaz O., Özyürek M., Augmented cytotoxicity of extramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation. Prostate Cancer and Prostatic Diseases, 2(S3): 33, 1999.

47. Özveren B., Türkeri L., Özyürek M., Akdaş A. Prognostic role of in vitro survival efficiency in human transitional cell carcinoma. Mol Urol., 3: 349-356, 1999.

46. Erkurt B., İlker Y., Budak Y., Özveren B., Türkeri L., Akdaş A. Effect of urinary stone disease and extracorporeal shock wave lithotripsy on excretion of glycosaminoglycans. J. Endourol., 13: 553-557, 1999.

45. Ertuğrul A., Türkeri L., Özyürek M., Özveri H., Akdaş A. Alteration of epidermal growth factor receptor expression following ischaemia of renal tissue. Int. Urol. Nephrol., 31: 611-617, 1999.

44. Toktaş G., Türkeri L., Ünlüer E., Çalışkan M., Aksoy B., Akdaş A. Clinical significance of nuclear p53 protein accumulation in bladder cancer. Int. Urol. Nephrol., 31: 327-334, 1999.

43. Toktaş G., Türkeri L., Ünlüer E., Atuğ F., Murat C., Özveren B., Çalışkan M., Akdaş A. Prognostic significance of p53 protein accumulation in stage pT1 transitional cell carcinoma of the bladder. Int. Urol. Nephrol., 31: 437-441, 1999.

42. Atuğ F., Türkeri L., Özyürek M., Akdaş A. Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder. Int. Urol. Nephrol., 30(4): 455-461, 1998.

41. Angulo J.C., Akdaş A., Eberle J.M., Haggman M., Malmstroöm P., Pontes JE., Sanchez-Chapado M., Türkeri L., Wood D.P. Jr. Comparison among patients considered candidates for radical prostatectomy in academic institutes in different countries (Comparacion entre pacientes considerados candidatos para prostatectomia radical en instituciones academicas de distintos paises). Arch. Esp. de Urol., 51 (10): 957-964, 1998.

40. Şimşek F., Türkeri L., Çevik İ., Bircan K., Akdaş A. Role of apoptosis in testicular tissue damage caused by varicocele. Arch. Esp. de Urol., 51 (9): 947-950, 1998.

39. Türkeri L., Erton M., Çevik İ., Akdaş A. The impact of the expression of epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor on the prognosis of superficial bladder cancer. Urology., 51: 645-649, 1998.

38. Türkeri L., Akdaş G., Özyürek M., Akdaş A. The role of in-vitro chemosensitivity test to predict the clinical efficacy of antineoplastic agents in genitourinary tumors. Arch. Esp. de Urol., 51 (4): 398-404, 1998.

37. Türkeri L., Daudi I., Abraham JL., Wojtowycz AR., and Haas GP. Cirsoid arteriovenous malformation of kidney presenting as a mass suggestive of malignancy. Int. J. Urol., 5: 96-99, 1998.

36. Türkeri L., Akdaş G., Özyürek M., Akdaş A. Calcium channel blockers counteract the cell cycle changes induced by chemotherapy in metastatic prostate cancer. J. BUON ., 3: 249-252, 1997.

35. Tarcan T., Özveri H., Biren T., Türkeri L., Akdaş A. Evaluation of prostate specific antigen density and transrectal ultrasonography-guided biopsies in 100 consecutive patients with a negative digital rectal examination and intermediate prostate specific antigen levels. Int. J. Urol., 4: 362-367, 1997.

34. Akdaş A., Çevik İ., Tarcan T., Türkeri L., Dalaman G., and Emerk K. The role of free prostate-specific antigen in the diagnosis of prostate cancer. Brit. J. Urol., 79: 920-923, 1997.

33. Çalışkan M., Türkeri L., Mansuroğlu B., Toktaş G., Aksoy B., Ünlüer E., Akdaş A. Nuclear accumulation of mutant p53 protein: a possible predictor of failure of intravesical therapy in bladder cancer. Brit. J. Urol., 79: 373-377, 1997.

32. Akdaş A., Tarcan T., Türkeri L., Biren T., Küllü S., İlker Y. The impact of prostate-Specific Antigen, its density and the Gleason Score in the prediction of extracapsular disease in prostate carcinoma. Eur. Urol., 31: 311-316, 1997.

31. Alkan İ., Türkeri L., Biren T., Çevik İ., Akdaş A. Volume determinations by transrectal ultrasonography in patients with benign prostatic hyperplasia: Correlation with removed prostate weight. Int. Urol. Nephrol., 28: 517-523, 1996.

30. Türkeri L., Tarcan T., Biren T., Küllü S., Akdaş A. Correlation of transrectal ultrasonography and core biopsies with pathology results in radical prostatectomy specimens. Int. J. Urol., 3: 459-461, 1996.

29. Türkeri L., Şimşek F., Sav A., İlker Y., Akdaş A. Enzymatic treatment of ileal segments used for urinary tract reconstruction. Int. Urol. Nephrol., 28: 655-663, 1996.

28. Tarcan T., Türkeri L., Biren T., Küllü S., Gürmen N., Akdaş A. The effectiveness of imaging modalities in clinical staging of localized prostatic carcinoma. Int. Urol. Nephrol., 28: 773-779, 1996.

27. Çevik İ., Türkeri L., Özveri H., İlker Y., Akdaş A. Short term effect of digital rectal examination on serum Prostate-Specific Antigen levels: A prospective study. Eur. Urol., 29: 403-406, 1996.

26. Akdaş A., Türkeri L., Küllü S., Tarcan T., Sakr W, Grignon DJ. Glutathione S-transferase and multidrug resistant phenotype in transitional cell carcinoma of the bladder. Eur. Urol., 29: 483-486, 1996.

25. Akdaş A., Tarcan T., Türkeri L., Çevik İ., Biren T., İlker Y. The impact of Prostate Specific Antigen density in predicting prostate cancer when serum Prostate-Specific Antigen levels are less than 10 ng/ml. Eur. Urol., 29: 189-192, 1996.

24. İlker Y., Türkeri L., Dillioğlugil Ö., Akdaş A. Spontaneous fracture of indwelling ureteral stents in patients treated with extracorporeal shock wave lithotripsy: Two case reports. Int. Urol. Nephrol.,  28: 15-19, 1996.

23. Çevik İ., Tarcan T., Türkeri L., Erkurt B., and Akdaş A. Comparison of urethral catheterization versus portable ultrasound scanning in the measurement of post-voiding residual urine volume. African J. Urol., 2: 36-40, 1996

22. İlker Y., Türkeri L., Tarcan T., Korten V., Akdaş A. Antimicrobial prophylaxis in management of urinary tract stones by extracorporeal shock wave lithotripsy (ESWL): Is it  necessary? Urology , 46: 165-167, 1995.

21. Türkeri L., Tarcan T., Biren T., Küllü S., Akdaş A. Transrectal ultrasonography versus digital guided prostate biopsies in patients with palpable lesions on digital rectal examination. Br. J. Urol. , 76: 184-186, 1995.

20. Akdaş A., Tarcan T., Türkeri L., Çevik İ., Biren T., Gürmen N. The diagnostic accuracy of digital rectal examination (DRE), transrectal ultrasound (TRUS), prostate specific antigen (PSA) and PSA density (PSAD) in prostate carcinoma (PCA). Br. J. Urol. 76: 54-56, 1995.

19. Çelikel Ç., Dillioğlugil Ö., Türkeri L., Başaran M., Yalçıner A., Küllü S., Akdaş A. Flow cytometric DNA studies and AgNOR counts in patients with transitional cell carcinoma (TCC) of the bladder. Eur. Urol. , 28: 152-157, 1995.

18. Türkeri L., Lum L.G., Uberti JP., Abella E., Karanes CFM.,Sensenbrenner LL and Haas G.P.: Continuous bladder irrigation in prevention of hemorrhagic cystitis due to cyclophosphamide based conditioning treatment for bone marrow transplantation. J. Urol., 153: 637-640, 1995.

17. İlker Y., Dillioğlugil Ö., Tarcan T., Türkeri L., Akdaş A.: The role of ureteroscopy as a diagnostic and therapeutic tool in various indications. Int. Urol. Nephrol., 26: 647-654, 1994.

16. Akdaş A., Türkeri L., İlker Y., Şimşek F., Emerk K.: Short term bioeffects of extracorporeal shock wave lithotripsy. J. Endourol., 8: 187-191, 1994

15. Türkeri L., Macoska J.A., Wykes S., Sakr W.A., and Pontes J.E.: Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant and malignant tissue from radical prostatectomy specimens. Prostate, 25: 199-205, 1994.

14. İlker Y., Alican Y., Şimşek F., Türkeri L., and Akdaş A.: Ureteral extracorporeal shock wave lithotripsy utilizing Dornier MFL 5000. J. Endourol., 8(1): 13-14, 1994.

13. Akdaş A., Türkeri L., Alican Y., Şimşek F., Akoğlu T.: Human Leukocyte Antigen subtype analysis in patients with advanced adenocarcinoma of the prostate. The Prostate, 24:111-113, 1994.

12. Macoska J.A., Benson P.D., Türkeri L., Haas G.P., and Sakr W.: PCR-based genetic analysis of DNA fom autopsied prostate tissue. PCR Methods and Applications, 2: 354-355, 1993.

11. İlker Y., Alican Y., Şimşek F., Türkeri L., Akdaş A.: Extracorporeal shock wave lithotripsy monotherapy of staghorn calculi with Dornier MFL 5000. J. Endourol., 7(4): 281-283, 1993.

10. Türkeri L., İlker Y., Şimşek F., Akdaş A.: Neoadjuvant (Induction) chemotherapy in advanced bladder carcinoma. Int. Urol. Nephrol., 25(3): 259-263, 1993.

 9. Akdaş A., Şimşek F., İlker Y.,  Türkeri L., Ercan H.: The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate. Int. Urol. Nephrol., 25(3): 271-278, 1993.

8. Akdaş A., Türkeri L., Ersev D., Ersev A., Küllü S.: Transurethral ultrasonography, fiberoptic cystoscopy and bladder washout cytology in the evaluation of bladder tumors. Int. Urol. Nephrol., 24(5): 503-508, 1992

7. Şimşek F., Türkeri L., İlker Y., Akdaş A.: Transurethral grooving of the prostate for the treatment of benign prostatic hyperplasia: An alternative to transurethral incision. Br. J. Urol., 72: 84-87, 1993.

6. Akdaş A., Türkeri L., The impact of squamous metaplasia in transitional cell carcinoma of the bladder . Int. Urol. Nephrol. 23(4): 333-336, 1991.

5. Şimşek F., Türkeri L., İlker Y., Akdaş A.: Severe obstruction of the urinary tract due to talcum powder granuloma. Case report. Int. Urol. Nephrol., 24(1): 31-34, 1992.

4. Şimşek F., İlker Y., Akdaş A., Türkeri L.: Teflon injection in the management of vesicoureteric reflux: A promising alternative for surgery. Int. Urol. Nephrol., 23(1): 27-30, 1991.

3. Akdaş A., Türkeri L., Akoğlu T.: Serum and urine levels of  Tumor Necrosis Factor in genitourinary tumors and its relevance to disease status. Int. Urol. Nephrol., 22(6): 501-506, 1990.

2.  Ersev A., Ersev D., Türkeri L., İlker Y., Şimşek F., Küllü S., Akdaş A.: The relation of prostatic acid phosphatase and prostate specific antigen with tumor grade in prostatic adenocarcinoma: An immunohistochemical study. Prostate Cancer and Testicular Cancer EORTC Genito-Urinary Group Monograph 7, Wiley Liss Inc., New York, 1990. Prog Clin Biol Res., 357:129-134, 1990.

1.  Türkeri L., Şimşek F., Akdaş A.: Urethral caruncle occuring in a prepubertal girl in an unusual location. Eur. Urol., 16: 153-154, 1989